Back to search

National and Kapodistrian University of Athens

Το διαλυτό CD146 ως πρωτότυπος ενθοθηλιακός δείκτης, σχετίζεται με την βαρύτητα της ηπατικής νόσου και την εξέλιξη σε κίρρωση

Abstract

dc:description

Angiogenesis and inflammation have been involved in the progression of fibrosis in patients with chronic liver disease (CLD). Soluble CD146 (sCD146), a biomarker which was recently characterized as a novel component of the endothelial junction is implicated in endothelial proliferation.Aim: To evaluate the performance of sCD146 in assessing liver fibrosis and cirrhosis and determine if its levels are related to the severity of liver disease in patients with cirrhosis.Methods: sCD146 levels were determined by a commercially available immunoenzymatic technique in sixty-two consecutive patients with cirrhosis, forty-three patients with CLD and twenty-seven healthy controls.Results: Patients with cirrhosis compared to non-cirrhotics with CLD had a higher median sCD146 concentration (639 vs 317 ng/ml). In receiver operating characteristic (ROC) curve analysis, the cut-off of 412 ng/ml showed a sensitivity of 78% and a specificity of 75% for diagnosis of cirrhosis, offering good diagnostic accuracy (AUROC:0.838). Patients with compensated compared to those with decompensated cirrhosis had a lower median sCD146 concentration (399 vs 848 ng/ml, respectively). A cut-off of 534 ng/ml offered a sensitivity of 83% and a specificity of 78% for differentiating compensated from decompensated cirrhosis (AUROC:0.866). Furthermore, in cirrhotics, sCD146 correlated positively with AST, bilirubin levels and most importantly with INR and MELD (r=0.648, P<0.001 and r=0.567, P<0.001, respectively).Conclusion: sCD146 can be used as a surrogate, inexpensive biomarker for the diagnosis of cirrhosis. It is also well correlated with severity of liver disease in cirrhotic patients.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2014

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Nomikou, Efrossyni
  • Νομικού, Ευφροσύνη

Subjects

dc:subject × 14

Rights

dc:rights
Statement dc:rights
  • BY_NC_SA
Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/42014

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Nomikou, Efrossyni; Νομικού, Ευφροσύνη. Το διαλυτό CD146 ως πρωτότυπος ενθοθηλιακός δείκτης, σχετίζεται με την βαρύτητα της ηπατικής νόσου και την εξέλιξη σε κίρρωση. National and Kapodistrian University of Athens, 2014. http://hdl.handle.net/10442/hedi/42014